The DOI matches its Crossref record.
Excerpts From the US Renal Data System 2009 Annual Data Report
Open accessOverview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The text we found for this paper looks like another document, so the self-check wasn’t run.
Citations
Cited by
Sorted by citations
Items 101–200 of 436
Prevention of Central Line–Associated Bloodstream Infections in Hemodialysis Patients
Boyce, J. M. (2012) · Infection Control and Hospital Epidemiology · doi:10.1086/667369 · Cited by 34
“disease (ESRD), with bacteremic sepsis causing 75% of infection-related deaths.(8) In a study of Staphylococcus aureus”
BackgroundBonato, F. O. B., Lemos, M. M., Cassiolato, J. L., & Canziani, M. E. F. (2013) · PLoS ONE · doi:10.1371/journal.pone.0066036 · Cited by 34
Jawdeh, B. G. A., Khan, S., Deschênes, I., Hoshi, M., Goel, M., Lock, J. T., Shinlapawittayatorn, K., Babcock, G., Lakhe-Reddy, S., DeCaro, G., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.212845 · Cited by 34
Brahmbhatt, A. N., Nieves-Torres, E., Yang, B., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0102542 · Cited by 34
Goldstein, S. L., Morris, D., & Warady, B. A. (2012) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2012.10.019 · Cited by 35
Wang, I., Lu, C., Lin, C., et al. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.05.036 · Cited by 34
Wu, M.-S., Wu, I., Shih, C.-P., et al. (2011) · Acta Nephrologica · Cited by 33
Kanazawa, Y., Nakao, T., Murai, S., et al. (2016) · Nephrology · doi:10.1111/nep.12814 · Cited by 33
Jurkovitz, C. T., Elliott, D. J., Li, S., Saab, G., Bomback, A. S., Norris, K. C., Chen, S., McCullough, P. A., & Whaley‐Connell, A. T. (2012) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2011.11.019 · Cited by 31
“Hypertension, diabetes, and hyperlipidemia are highly prevalent in patients with end-stage renal disease or CKD.(1,3) Of National Health and Nutrition Examination Survey (NHANES) participants with eGFR 60 mL/min/1.”
BackgroundInfluentialSelf-citationMYERS, J. N., Chan, K., Chen, Y., Lit, Y., Patti, A., Massaband, P., Kiratli, B. J., Tamura, M., Chertow, G. M., & Rabkin, R. (2021) · Kidney & Blood Pressure Research · doi:10.1159/000514269 · Cited by 31
Vascular Endothelial Cadherin Modulates Renal Interstitial Fibrosis
Yamaguchi, I., Tchao, B. N., Burger, M. L., et al. (2011) · Nephron Experimental Nephrology · doi:10.1159/000332026 · Cited by 31
Rteil, A., Kazma, J. M., Sawda, J. E., Gharamti, A. A., Koubar, S. H., & Kanafani, Z. A. (2020) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2020.01.314 · Cited by 35
Park, J. I., Bae, E., Kim, Y.-L., Kang, S., Yang, C. W., Kim, N., Lee, J. P., Kim, D. K., Joo, K. W., Kim, Y. S., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0136085 · Cited by 30
Silva, T. M. C., Alves, L. A. C., Garrido, D., et al. (2019) · Quality of Life Research · doi:10.1007/s11136-019-02196-8 · Cited by 30
“4 cases pmarp in end-stage renal disease in patients under 18 years old [2, 3].”
BackgroundEgyptian renal data system (ERDS) 2020
Hassaballa, M. A., El-Wakil, H. S., Elsharkawy, M. M., et al. (2022) · Journal of The Egyptian Society of Nephrology and Transplantation · doi:10.4103/jesnt.jesnt_37_21 · Cited by 30
The influence of UGT polymorphisms as biomarkers in solid organ transplantation
Dupuis, R. E., Yuen, A., & Innocenti, F. (2012) · Clinica Chimica Acta · doi:10.1016/j.cca.2012.01.031 · Cited by 30
Konta, T., Ikeda, A., Ichikawa, K., Fujimoto, S., Iseki, K., Moriyama, T., Yamagata, K., Tsuruya, K., Yoshida, H., Asahi, K., et al. (2011) · American Journal of Hypertension · doi:10.1038/ajh.2011.217 · Cited by 30
Mo, X. L., Meng, H. Y., Wu, Y. Y., et al. (2022) · Journal of Clinical Medicine Research · doi:10.14740/jocmr4621 · Cited by 29
“It is predicted that by 2030, the number of patients requiring dialysis or transplantation due to renal failure will exceed 2 million [2, 3].”
BackgroundHidden targets of ubiquitin proteasome system: To prevent diabetic nephropathy
Goru, S. K., Kadakol, A., & Gaikwad, A. B. (2017) · Pharmacological Research · doi:10.1016/j.phrs.2017.03.024 · Cited by 30
Nelveg-Kristensen, K. E., Laier, G. H., & Heaf, J. G. (2018) · BMC Infectious Diseases · doi:10.1186/s12879-018-3594-7 · Cited by 29
Nephrologist Caseload and Hemodialysis Patient Survival in an Urban Cohort
Harley, K. T., Streja, E., Rhee, C. M., et al. (2013) · Journal of the American Society of Nephrology · doi:10.1681/asn.2013020123 · Cited by 28
Cell cycle re-entry sensitizes podocytes to injury induced death
Hagen, M., Pfister, E., Kosel, A., et al. (2016) · Cell Cycle · doi:10.1080/15384101.2016.1191710 · Cited by 28
“In the United States alone, more than 500,000 patients have ESRD, with costs exceeding $35 billion per year.(2) Increasing evidence shows that loss of podocytes may be a crucial factor underlying glomerulosclerosis in classic proteinuric glomerular diseases.”
BackgroundPermanent cardiac pacing in patients with end-stage renal disease undergoing dialysis
Wang, I., Lin, K., Lin, S.-Y., Lin, C., Chang, C., Yen, T., & Sung, F. (2016) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfw302 · Cited by 27
Lee, J.-E., Lim, J., Jang, H. M., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0185853 · Cited by 28
Association of education level with dialysis outcome
Khattak, M., Sandhu, G. S., DeSilva, R. N., et al. (2011) · Hemodialysis International · doi:10.1111/j.1542-4758.2011.00615.x · Cited by 27
Park, K. S., Chang, J. W., Kim, T. Y., Kim, H. W., Lee, E. K., Kim, H., Yang, W. S., Kim, S. B., Park, S.-K., Lee, S. K., et al. (2011) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.110.001974 · Cited by 28
Said, A., Desai, C., & Lerma, E. V. (2015) · Disease-a-Month · doi:10.1016/j.disamonth.2015.08.001 · Cited by 27
Yang, C. W., Park, J. T., Kim, Y. S., Kim, Y. L., Lee, Y.-S., Oh, Y.-S., & Kang, S. (2011) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfr011 · Cited by 27
“Diabetic nephropathy is the leading cause of end-stage renal disease (ESRD) worldwide [6].”
BackgroundYang, H., Chen, Y.-H., Hsieh, T., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0154627 · Cited by 26
“Considering the major causes of death in the dialysis patient population that include cardiovascular disease, infection, and withdrawn from dialysis, cardiovascular disease accounts for approximately 50 percent of deaths [2].”
BackgroundNoninvasive Vascular Imaging in Abdominal Solid Organ Transplantation
Norton, P. T., DeAngelis, G. A., Oğur, T., et al. (2013) · American Journal of Roentgenology · doi:10.2214/ajr.13.11306 · Cited by 26
Chung, C., Lin, M., Hsu, J., Hsiao, J., Chang, S., Pan, K., Lin, C., & Lin, Y. (2017) · Journal of clinical lipidology · doi:10.1016/j.jacl.2017.01.001 · Cited by 25
Wallace, Z. S., Wallwork, R. S., Zhang, Y., Lu, N., Cortazar, F. B., Niles, J. L., Heher, E. C., Stone, J. H., & Choi, H. K. (2018) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2018-213452 · Cited by 27
Garg, L., Chen, C., & Haines, D. E. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.07.118 · Cited by 26
“6 times greater in dialysis patients than in those with a renal transplant [25].”
BackgroundInfluentialKałużna, M., Hoppe, K., Schwermer, K., Ibrahim, A. Y., Pawlaczyk, K., & Ziemnicka, K. (2016) · Polskie Archiwum Medycyny Wewnętrznej · doi:10.20452/pamw.3466 · Cited by 25
Rodriguez-Giron, L. J., Tighiouart, H., Scott, T. M., Lou, K. V., Giang, L. M., Sorensen, E. P., Weiner, D. E., & Sarnak, M. J. (2012) · Journal of Nephrology · doi:10.5301/jn.5000131 · Cited by 25
Lertdumrongluk, P., Streja, E., Rhee, C. M., et al. (2015) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.09000914 · Cited by 25
Genetics of Type 2 Diabetes in African Americans
Ng, M. C. Y. (2015) · Current Diabetes Reports · doi:10.1007/s11892-015-0651-0 · Cited by 24
Tarantal, A. F., Lee, C. C. I., Batchelder, C. A., Christensen, J. E., Prater, D. N., & Cherry, S. R. (2011) · Molecular Imaging and Biology · doi:10.1007/s11307-011-0487-1 · Cited by 24
Wang, I., Lin, C., Lin, P., et al. (2015) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfv360 · Cited by 24
New EGFR inhibitor, 453, prevents renal fibrosis in angiotensin II-stimulated mice
Skibba, M. E., Qian, Y., Bao, Y., et al. (2016) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2016.08.009 · Cited by 24
Body mass index and mortality in patients on maintenance hemodialysis: a meta-analysis
Li, T., Liu, J., An, S., Dai, Y. M., & Yu, Q. (2014) · International Urology and Nephrology · doi:10.1007/s11255-014-0653-x · Cited by 23
“A high annual mortality of approximately 20 % has been determined in this population in the USA [3], and greater than 60 % of the patients die within 5 years of the initial dialysis [4]; approximately 45 % of these deaths are attributed to cardiovascular causes [1, 2].”
BackgroundSelf-citationDiagnosis and management of chronic kidney disease in the elderly: a field of ongoing debate.
Dousdampanis, P., Trigka, K., & Fourtounas, C. (2012) · Europe PMC (PubMed Central) · Cited by 23
Superior Patency of Upper Arm Arteriovenous Fistulae in High Risk Patients
Chiulli, L. C., Vasilas, P., & Dardik, A. (2011) · Journal of Surgical Research · doi:10.1016/j.jss.2011.03.042 · Cited by 23
Store-operated calcium entry and diabetic complications
Chaudhari, S. K., & Ma, R. (2015) · Experimental Biology and Medicine · doi:10.1177/1535370215609693 · Cited by 22
“Diabetic nephropathy, one of the most common complications of diabetes mellitus, is a major cause of end stage renal disease.(68,69) Early features of diabetic nephropathy include glomerular hypertrophy with thickening of the glomerular basement membrane and expansion of the glomerular mesangium, which eventually deve…”
BackgroundSchmaderer, C., Tholen, S., Hasenau, A.-L., Hauser, C., Suttmann, Y., Wassertheurer, S., Mayer, C. C., Bauer, A., Rizas, K. D., Kemmner, S., et al. (2016) · BMC Nephrology · doi:10.1186/s12882-016-0374-8 · Cited by 27
“For example the overall life expectancy of a patient after initiation of dialysis is 8 years in the age group of 40 to 44 years, compared to 30 to 40 years of life expectancy in the general population [3].”
BackgroundComparison of the Development Diabetic Induced Renal Disease in Strains of Goto-Kakizaki Rats
Kojima, N. (2013) · Journal of Diabetes & Metabolism · doi:10.4172/2155-6156.s9-005 · Cited by 22
“Diabetic nephropathy is the leading cause of End-Stage renal disease (ESRD) in the United States [1].”
BackgroundPrevalência estimada da doença renal crônica terminal em crianças no Estado de São Paulo
Nogueira, P. C. K., Feltran, L. D. S., de Camargo, M. F. C., et al. (2011) · Revista da Associação Médica Brasileira · doi:10.1590/s0104-42302011000400020 · Cited by 22
Chou, C., Hsieh, T., Wang, C., Hung, T., Lai, Y., Chen, Y.-Y., Lin, Y., Kuo, C., Wu, Y.-J., & Fang, T. (2014) · Archives of Medical Research · doi:10.1016/j.arcmed.2014.01.009 · Cited by 21
Self-citationLee, J., An, J. N., Hwang, J. H., Kim, Y.-L., Kang, S., Yang, C. W., Kim, N., Oh, Y. K., Lim, C. S., Kim, Y. S., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0105532 · Cited by 22
Kaddourah, A., Uthup, S., Madueme, P. C., et al. (2015) · Clinical Nephrology · doi:10.5414/cn108489 · Cited by 22
“Model 2 includes the clinical variables that are known to be associated with CVD in addition to the variables included in model 1.”
BackgroundInfluentialLin, W., Chao, C., Liu, H.-C., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0125496 · Cited by 22
Wu, P.-Y., Yang, S., Wong, T.-C., Chen, T.-W., Chen, H.-H., Chen, T.-H., & Chen, Y.-T. (2015) · PLoS ONE · doi:10.1371/journal.pone.0141917 · Cited by 23
Pohjolainen, V., Rysä, J., Näpänkangas, J. P., et al. (2011) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfr279 · Cited by 22
“Cardiovascular mortality accounts for the major part of all deaths in patients with chronic kidney disease [1, 2].”
BackgroundHuang, S., Yu, T., Ke, T.-Y., Wu, M., Chuang, Y., Li, C., Chiu, C.-W., Lin, C., Liang, W., Chou, T., et al. (2018) · Journal of Clinical Medicine · doi:10.3390/jcm7100344 · Cited by 21
“The increased incidence of CVD in patients undergoing dialysis is attributed to increased prevalence of traditional risk factors for CVD such as diabetes mellitus (DM), dyslipidemia, hypertension [1,2], and risk factors due to loss of renal function [3].”
BackgroundHsieh, T., Chou, C., Chen, J.-S., Kuo, C., Wang, Y.-C., Lai, Y., Lin, Y., Wang, C., & Fang, T. (2015) · JAMA Ophthalmology · doi:10.1001/jamaophthalmol.2015.5052 · Cited by 21
Self-citationGalectin-3 as a new biomarker of diastolic dysfunction in hemodialysis patients
Gurel, O. M., Yılmaz, H., Çelik, T., et al. (2015) · Herz · doi:10.1007/s00059-015-4303-6 · Cited by 21
Sun, H., Ke, C., Zhang, L., Tian, C., Zhang, Z., & Wu, S. (2020) · Medical Science Monitor · doi:10.12659/msm.922029 · Cited by 21
“Current treatment is only effective in delaying kidney disease progression without the use of radical treatment and the survival rate is very poor [3,4].”
BackgroundContou, D., d’Ythurbide, G., Messika, J., et al. (2013) · Journal of Infection · doi:10.1016/j.jinf.2013.10.003 · Cited by 21
Walker, J. P., Hiramoto, J. S., Gasper, W. J., et al. (2014) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2014.01.037 · Cited by 21
“These values in older patients are only slightly better than those in patients with lung cancer and are much worse than those for the general population, which is 30 to 40 years for those aged 40 to 44 years and 17 to 22 years for individuals aged 60 to 64.(3) Performance of a successful HD procedure requires a functi…”
BackgroundChou, M., Wang, J., Wu, W.-S., et al. (2014) · International Journal of Cardiology · doi:10.1016/j.ijcard.2014.11.083 · Cited by 20
Fujikawa, T., Ikeda, Y., Fukuhara, S., et al. (2013) · Nephron Clinical Practice · doi:10.1159/000346740 · Cited by 20
Palliative Care in CKD: The Earlier the Better
Germain, M. J., Tamura, M. K., & Davison, S. N. (2010) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2010.12.001 · Cited by 20
Cardiac Surgery in Patients With Previous Hepatic or Renal Transplantation: A Pair-Matched Study
Farag, M. B., Nikolic, M., Arif, R., et al. (2016) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2016.08.092 · Cited by 20
Hegner, B., Schaub, T., Janke, D., Zickler, D., Lange, C., Girndt, M., Jankowski, J., Schindler, R., & Dragun, D. (2018) · Scientific Reports · doi:10.1038/s41598-018-30626-z · Cited by 20
Saad, M., Karam, B., Faddoul, G., et al. (2016) · International Journal of Nephrology and Renovascular Disease · doi:10.2147/ijnrd.s91567 · Cited by 20
“Significant data regarding inpatient care of patients with CKD and ESRD presenting with ACS come from Medicare and Medicare data reports available from the United States Renal Data System, which reported significant disparities in care in patients with CKD and ESRD.(7) Another report from the National Cardiovascular D…”
InfluentialEstimated prevalence of childhood end-stage renal disease in the state of São Paulo
Nogueira, P. C. K., Feltran, L. D. S., de Camargo, M. F. C., et al. (2011) · Revista da Associação Médica Brasileira (English Edition) · doi:10.1016/s2255-4823(11)70091-1 · Cited by 20
Sharma, R. K., Hawley, C. M., Griffin, R., et al. (2012) · Interactive Cardiovascular and Thoracic Surgery · doi:10.1093/icvts/ivs442 · Cited by 19
Contrast-Induced Nephropathy and the Vascular Patient
Paraskevas, K. I., Giannoukas, A. D., Kotsikoris, I., et al. (2010) · Angiology · doi:10.1177/0003319710379110 · Cited by 19
“Additionally, diabetes mellitus is the cause of kidney failure in almost 1 of 2 dialysis patients.(24) Both CKD(24) and diabetes mellitus(25) are associated with higher mortality rates compared with the age- and gender-matched general population.”
BackgroundIncreased oxidative stress in diabetic nephropathy and its relationship with soluble Klotho levels.
İnci, A., Olmaz, R., Sarı, F., et al. (2016) · PubMed · Cited by 19
Seo, S. M., Kim, S. H., Kim, Y., et al. (2018) · International Journal of Medical Sciences · doi:10.7150/ijms.23638 · Cited by 19
“Although there have been tremendous improvements in the quality and utility of dialysis in recent years, death from cardiovascular events is still the biggest problem of dialysis (4).”
BackgroundDonor race and outcomes in kidney transplant recipients
Molnar, M. Z., Kovesdy, C. P., Bunnapradist, S., et al. (2012) · Clinical Transplantation · doi:10.1111/j.1399-0012.2012.01686.x · Cited by 19
Baek, I., Bai, C. Z., Hwang, J., et al. (2012) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2011.09.012 · Cited by 19
The Interaction of Race, Poverty, and CKD
Young, B. A. (2010) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2010.04.008 · Cited by 19
Impact of parathyroidectomy on survival among haemodialysis patients: A prospective cohort study
Li, W., Zhang, M., Du, S., et al. (2015) · Nephrology · doi:10.1111/nep.12564 · Cited by 18
“The United States Renal Data System (USRDS) has shown that 92% of 111 000 patients with ESRD received haemodialysis treatment.(4) Despite the rapid development of dialysis technology, patients with ESRD still have a higher risk of cardiovascular morbidity.”
BackgroundSelf-citationRole and Association of Inflammatory and Apoptotic Caspases in Renal Tubulointerstitial Fibrosis
Ke, Y., Tang, H., Ye, C., et al. (2016) · Kidney & Blood Pressure Research · doi:10.1159/000447933 · Cited by 18
Weir, M. A., Walsh, M. W., Cuerden, M. S., Sontrop, J. M., Chambers, L. C., & Garg, A. X. (2018) · Canadian Journal of Kidney Health and Disease · doi:10.1177/2054358118813088 · Cited by 18
Subdural hematoma in patients with end‐stage renal disease receiving hemodialysis
Wang, I. ‐., Lin, C., Wu, Y. Y., et al. (2014) · European Journal of Neurology · doi:10.1111/ene.12406 · Cited by 18
“Previous research indicated that the survival rate of dialysis patients was lowest during the first year of dialysis [24].”
BackgroundDiagnosis and Treatment of Glomerular Diseases in Elderly Patients
Qian, Q., & Nasr, S. H. (2014) · Advances in Chronic Kidney Disease · doi:10.1053/j.ackd.2014.01.004 · Cited by 18
Toxicology of freshwater cyanobacteria
Liyanage, H. M., Magana-Arachchi, D., Abeysekara, T., & Lishantha, G. (2016) · Journal of Environmental Science and Health Part C · doi:10.1080/10590501.2016.1193923 · Cited by 18
Hemoglobin A1c in Hemodialysis Patients
Ix, J. H. (2010) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.04410510 · Cited by 18
Wyngaert, K. V., Biesen, W. V., Eloot, S., et al. (2022) · PLoS ONE · doi:10.1371/journal.pone.0268115 · Cited by 17
“Second, after CV disease and infections, withdrawal from dialysis due to cachexia is the third most common cause of death (15–25% of all-cause mortality) in patients on haemodialysis in the United States [35], in which the quality of life is a major decisive component [50].”
BackgroundInfluentialChromatin Methylation Abnormalities in Autosomal Dominant Polycystic Kidney Disease
Xu, J., Xue, C., Wang, X., Zhang, L., Mei, C., & Mao, Z. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.921631 · Cited by 17
“Autosomal dominant polycystic kidney disease (ADPKD) is the most common form of inherited kidney disease and is one of the major causes of end-stage kidney disease (ESKD), affecting 1 in 2,500 to 1,000 individuals worldwide (1, 2).”
BackgroundSelf-citationHorowitz, L., Karadjian, O. A., Braam, B., et al. (2023) · Canadian Journal of Kidney Health and Disease · doi:10.1177/20543581231185433 · Cited by 17
“Luo et al20 2011 PD — — — X — Onofriescu et al21 2012 HD — — — X — Hur et al22 2013 HD X (6) — — X X Onofriescu et al23 2014 HD X (9) — — X — Ponce et al24 2014 HD X (6) X — X — Huan-Sheng et al25 2016 HD X (13) X CV-related events-free survival — —”
Management of acute intradialytic cardiovascular complications: Updated overview (Review)
Timofte, D., Tănăsescu, M., Balan, D., Tulin, A., Știru, O., Vacaroiu, I., Mihai, A., Popa, C., Cosconel, C.-I., Enyedi, M., et al. (2021) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2021.9713 · Cited by 15
Predicting hospital mortality in COVID‐19 hemodialysis patients with developed scores
Sevinç, C., Demirci, R., & Timur, Ö. (2021) · Seminars in Dialysis · doi:10.1111/sdi.13004 · Cited by 17
“HD patients have a high risk of COVID 19 infection due to both the CKD itself and its existing comorbidities.(13,14) In this study involving 117 patients, the most common symptoms at the time of admission to hospital were cough, myalgia fever, and shortness of breath.”
BackgroundCardiac imaging for the assessment of patients being evaluated for kidney transplantation
Kassab, K., & Doukky, R. (2021) · Journal of Nuclear Cardiology · doi:10.1007/s12350-021-02561-6 · Cited by 16
Weiner, D. E., & Watnick, S. G. (2010) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2009.12.005 · Cited by 17
Cost-effectiveness of continuous erythropoietin receptor activator in anemia
Schmid, H. (2014) · ClinicoEconomics and Outcomes Research · doi:10.2147/ceor.s46930 · Cited by 16
“Although ESA therapy can often result in dramatic benefits initially, long-term improvement in outcomes is disappointing, particularly in patients with CKD or end-stage renal disease.(9) Furthermore, randomized controlled trials in CKD patients not on dialysis, with or without diabetes, resulted in serious concerns ab…”
Wang, I., Liang, W., Lin, C., et al. (2015) · International Urology and Nephrology · doi:10.1007/s11255-015-1157-z · Cited by 16
“In patients with end-stage renal disease (ESRD), over 40 % of all deaths are attributable to cardiovascular disease (CVD) [1].”
BackgroundChronic Heart Failure and Comorbid Renal Dysfunction - A Focus on Type 2 Cardiorenal Syndrome
Jois, P., Alexandre, M., Iyngkaran, P., et al. (2016) · Current Cardiology Reviews · doi:10.2174/1573403x12666160606120958 · Cited by 16
“We know similarly that in isolation, CHF averages a 50% 5-year mortality and End Stage Renal Failure (ESRF) similarly [17, 18].”
BackgroundHuang, L., Langerak, A. W., Baan, C. C., Litjens, N. H. R., & Betjes, M. G. H. (2016) · Clinical & Experimental Immunology · doi:10.1111/cei.12846 · Cited by 16
Effect of Acupuncture or Massage on Health-Related Quality of Life of Hemodialysis Patients
Bullen, A. L., Awdishu, L., Lester, W., Moore, T., & Trzebinska, D. (2018) · The Journal of Alternative and Complementary Medicine · doi:10.1089/acm.2018.0030 · Cited by 16
“Moreover, HD patients may have other medical conditions (diabetes mellitus and cardiovascular disease being the most common), which contribute to chronic pain, HR-QOL, and other psychological distress.(7,10,11) Decreased QOL in patients undergoing HD is a well described problem.”
BackgroundGoru, S. K., & Gaikwad, A. B. (2017) · Pharmacological Reports · doi:10.1016/j.pharep.2017.11.018 · Cited by 16
Freercks, R., Swanepoel, C. R., Carrara, H., Moosa, S., Lachman, A. S., & Rayner, B. L. (2012) · Nephrology · doi:10.1111/j.1440-1797.2012.01612.x · Cited by 17
Dalal, D., de Jong, J. S. S. G., Tjong, F. V. Y., et al. (2011) · Heart Rhythm · doi:10.1016/j.hrthm.2011.11.014 · Cited by 15
Hyun, S.-H., Choi, J., Cho, J., et al. (2014) · Blood Purification · doi:10.1159/000360272 · Cited by 15
Williams, E. S., Shah, S. H., Piccini, J. P., et al. (2011) · EP Europace · doi:10.1093/europace/eur253 · Cited by 15
Survival rate and predictors of mortality among hemodialysis patients in West of Iran, 1996–2015
Mansournia, M. A., Khazaei, S., Yaseri, M., et al. (2018) · International Journal of Preventive Medicine · doi:10.4103/ijpvm.ijpvm_399_16 · Cited by 15
Cardiovascular Benefits of Extended-Time Nocturnal Hemodialysis
Roumeliotis, A. K., Roumeliotis, S. K., Chan, C. T., & Pierratos, A. (2020) · Current Vascular Pharmacology · doi:10.2174/1570161118666200401112106 · Cited by 15
Turner, S. T., Rule, A. D., Schwartz, G. L., et al. (2011) · Journal of Hypertension · doi:10.1097/hjh.0b013e328349052b · Cited by 15
Metadata
- Authors
- Collins, A. J., Foley, R. N., Herzog, C., Chavers, B. M., Gilbertson, D., Ishani, A., Kasiske, B. L., Liu, J., Mau, L.-W., McBean, M., Murray, A., St. Peter, W., Guo, H., Li, Q., Li, S., Li, S., Peng, Y., Qiu, Y., Roberts, T., Skeans, M., Snyder, J., Solid, C., Wang, C., Weinhandl, E., Zaun, D., Arko, C., Chen, S.-C., Dalleska, F., Daniels, F., Dunning, S., Ebben, J., Frazier, E., Hanzlik, C., Johnson, R., Sheets, D., Wang, X., Forrest, B., Constantini, E., Everson, S., Eggers, P. W., & Agodoa, L.
- Affiliations
- United States Department of Veterans Affairs (US)
- ORCID
- Venue
- American Journal of Kidney Diseases
- Publisher
- Elsevier BV
- Published
- 2010-01
- Volume
- 55
- Issue
- 1
- Pages
- A6-A7
- ISSN
- 0272-6386 (ISSN-L)
- PMC
- PMC2829836
- OpenAlex
- W1955298113
- Cited by
- 436
- References
- 0
- Citations by year
- 2026: 6 · 2025: 10 · 2024: 12 · 2023: 18 · 2022: 19 · 2021: 22 · 2020: 20 · 2019: 23 · 2018: 35 · 2017: 25 · 2016: 34 · 2015: 40 · 2014: 29 · 2013: 42 · 2012: 37
- FWCI
- 19.56
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- American Journal of Kidney Diseases (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases (HHSN 267 2007 15002C/N01-DK-7-5002, HHSN267200715002C)
- Topics
- Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
- Health Sciences › Medicine › Nephrology › Dialysis and Renal Disease Management
- Health Sciences › Medicine › Nephrology › Acute Kidney Injury Research
- Keywords
- chronic kidney disease, end-stage renal disease, acute kidney injury, mortality risk, blood pressure control, lipid control, health care costs, morbidity, NHANES
- MeSH terms
- Chronic Disease, Medicare, Renal Dialysis, Humans, Kidney Diseases, United States, Kidney Transplantation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
